Delivery of biomolecules to immune cells
US-2018142198-A1 · May 24, 2018 · US
US10696944B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10696944-B2 |
| Application number | US-201214352354-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 17, 2012 |
| Priority date | Oct 17, 2011 |
| Publication date | Jun 30, 2020 |
| Grant date | Jun 30, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A microfluidic system for causing perturbations in a cell membrane, the system including a microfluidic channel defining a lumen and being configured such that a cell suspended in a buffer can pass therethrough, wherein the microfluidic channel includes a cell-deforming constriction, wherein a diameter of the constriction is a function of the diameter of the cell.
Opening claim text (preview).
What is claimed is: 1. A method for delivering a payload into a cell, the method comprising: providing a cell in a suspension solution; passing the solution through a microfluidic channel that includes a cell-deforming constriction, wherein a diameter of the constriction is 20-99% of a diameter of the cell in the suspension solution such that a deforming force is applied to the cell as it passes through the constriction thereby causing perturbations of the cell large enough for…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.